HRAS and esophageal squamous cell carcinoma: In esophageal cancer, LEF1 activates the ERK/MAPK signaling pathway via the Id3/HRAS axis, thereby promoting the development and progression of esophageal squamous cell carcinoma (ESCC) [39].